Nisar Baig

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Daratumumab interference in flow cytometric anti‐granulocyte antibody testing can be overcome using non‐human blocking antibodies
  Vox Sanguinis 2021 6 citations DOI: 10.1111/vox.12989
  +Save
• The 'HLA conundrum in bone marrow transplantation': correct interpretation of anti-HLA antibodies in haploidentical donor selection.
  Bone marrow transplantation 2017 2 citations DOI: 10.1038/bmt.2017.13
  +Save
• Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages.
  Clinical and experimental immunology 2015 51 citations DOI: 10.1111/cei.12697
  +Save
• Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.
  American journal of hematology 2014 36 citations DOI: 10.1002/ajh.23737
  +Save
• Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia.
  Journal of immunology (Baltimore, Md. : 1950) 2014 54 citations DOI: 10.4049/jimmunol.1302954
  +Save
• Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement.
  Leukemia & lymphoma 2012 46 citations DOI: 10.3109/10428194.2012.681657
  +Save